Výsledky vyhledávání - "L L, Rosendorf"

Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MEL

Autor: R P, Mischak, C, Foxall, L L, Rosendorf, K, Knebel, P J, Scannon, L E, Spitler

Publikováno v: Molecular biotherapy. 2(2)

Human antibody responses to immunotoxin components were evaluated in 21 melanoma patients who were treated with XomaZyme-MEL, a murine monoclonal antimelanoma antibody-ricin A chain conjugate. Twenty of the 21 melanoma patients produced antibodies ag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4c230f38354fdd18c7a78f920efa232e
https://pubmed.ncbi.nlm.nih.gov/2363853

Zobrazit plný text záznamu

[Proceedings: Transduction and genetic analysis of antibiotic resistance in Staphylococcus epidermidis]

Autor: L L, Rosendorf, F H, Kayser

Publikováno v: Pathologia et microbiologia. 41(3-4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::64b83d75c90f278eac528d3aaa72d505
https://pubmed.ncbi.nlm.nih.gov/4444824

Zobrazit plný text záznamu

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin

Autor: L E, Spitler, M, del Rio, A, Khentigan, N I, Wedel, N A, Brophy, L L, Miller, W S, Harkonen, L L, Rosendorf, H M, Lee, R P, Mischak

Publikováno v: Cancer research. 47(6)

We conducted a trial of a murine monoclonal antimelanoma antibody-ricin A chain immunotoxin (XOMAZYME-MEL) in 22 patients with metastatic malignant melanoma. The dose of immunotoxin administered ranged from 0.01 mg/kg daily for 5 days to 1 mg/kg dail

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::197116ded51fcb34917fc2c4947db3cb
https://pubmed.ncbi.nlm.nih.gov/3493066

Zobrazit plný text záznamu

Sources of gram-negative infection after open-heart surgery

Autor: L L, Rosendorf, G, Daicoff, H, Baer

Publikováno v: The Journal of thoracic and cardiovascular surgery. 67(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f912c05d17f39c74f14d33912ca30c40
https://pubmed.ncbi.nlm.nih.gov/4204248

Zobrazit plný text záznamu

Phase 1 immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody

Autor: C E Reinhold, A Khentigan, H.M. Lee, L L Rosendorf, Lynn E. Spitler, S W Corpuz, Barry L. Engelstad, M J Del Rio, John P. Huberty, E C Ramos

Publikováno v: Radiology. 161(2)

A phase 1 study was conducted using a monoclonal antimelanoma antibody-DTPA conjugate labeled with indium-111, for immunolymphoscintigraphy in patients with metastatic melanoma. The imaging agent, labeled with 1 mCi (37 MBq) In-111, was administered

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa4bdd16029a1ac3ea58374369eb67bc
https://pubmed.ncbi.nlm.nih.gov/3763912

Zobrazit plný text záznamu